Ieq Capital LLC Invests $11.61 Million in Danaher Corporation $DHR

Ieq Capital LLC bought a new stake in shares of Danaher Corporation (NYSE:DHR) in the second quarter, Holdings Channel reports. The institutional investor bought 60,943 shares of the conglomerate’s stock, valued at approximately $11,609,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of DHR. Main Street Group LTD purchased a new stake in Danaher during the first quarter valued at $25,000. N.E.W. Advisory Services LLC bought a new position in Danaher during the second quarter valued at $25,000. JPL Wealth Management LLC purchased a new position in shares of Danaher in the 3rd quarter worth $25,000. WFA of San Diego LLC purchased a new position in shares of Danaher in the 2nd quarter worth $26,000. Finally, Hilton Head Capital Partners LLC bought a new stake in shares of Danaher in the 4th quarter worth about $27,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Danaher Stock Up 1.6%

Shares of NYSE:DHR opened at $219.42 on Friday. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80. The business has a 50 day simple moving average of $195.80 and a two-hundred day simple moving average of $192.61. The firm has a market capitalization of $154.25 billion, a PE ratio of 38.97, a price-to-earnings-growth ratio of 2.72 and a beta of 0.78. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25.

Danaher (NYSE:DHR) last released its earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The firm had revenue of $6.26 billion for the quarter, compared to analysts’ expectations of $6.12 billion. During the same quarter in the prior year, the firm posted $0.77 earnings per share. The company’s quarterly revenue was up 5.5% on a year-over-year basis. On average, equities analysts predict that Danaher Corporation will post 8.53 EPS for the current year.

Wall Street Analysts Forecast Growth

DHR has been the topic of several recent research reports. DZ Bank started coverage on shares of Danaher in a research report on Wednesday, June 3rd. They set a “buy” rating and a $210.00 target price on the stock. Citigroup initiated coverage on Danaher in a research report on Tuesday, May 26th. They issued a “buy” rating and a $230.00 price target for the company. HSBC decreased their price objective on Danaher from $270.00 to $230.00 and set a “buy” rating on the stock in a research report on Wednesday, June 3rd. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a $240.00 price objective on shares of Danaher in a research note on Wednesday, July 22nd. Finally, Wall Street Zen cut Danaher from a “buy” rating to a “hold” rating in a report on Saturday, April 25th. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat, Danaher has a consensus rating of “Moderate Buy” and a consensus price target of $228.91.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.